The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial

A. Masurekar; C. Fong; A. Hussein; T. Revesz; P. M. Hoogerbrugge; S. Love; C. Ciria; C. Parker; S. Krishnan; V. Saha

doi:10.1038/bcj.2014.26

The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial

A. Masurekar, C. Fong, A. Hussein, T. Revesz, P. M. Hoogerbrugge, S. Love, C. Ciria, C. Parker, S. Krishnan, V. Saha

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e203
Journal	Blood cancer journal
Volume	4
Issue number	4
DOIs	https://doi.org/10.1038/bcj.2014.26
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bcj.2014.26

http://www.nature.com/bcj/index.html

Cite this

@article{b23be42f9eb64a9e94121b13ac9390e0,

title = "The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial",

author = "A. Masurekar and C. Fong and A. Hussein and T. Revesz and Hoogerbrugge, {P. M.} and S. Love and C. Ciria and C. Parker and S. Krishnan and V. Saha",

year = "2014",

doi = "10.1038/bcj.2014.26",

language = "English",

volume = "4",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "4",

}

TY - JOUR

T1 - The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial

AU - Masurekar, A.

AU - Fong, C.

AU - Hussein, A.

AU - Revesz, T.

AU - Hoogerbrugge, P. M.

AU - Love, S.

AU - Ciria, C.

AU - Parker, C.

AU - Krishnan, S.

AU - Saha, V.

PY - 2014

Y1 - 2014

U2 - 10.1038/bcj.2014.26

DO - 10.1038/bcj.2014.26

M3 - Article

C2 - 24769644

SN - 2044-5385

VL - 4

JO - Blood cancer journal

JF - Blood cancer journal

IS - 4

M1 - e203

ER -